Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $3,055 | 4 | 93.9% |
| Food and Beverage | $196.90 | 3 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $3,000 | 2 | $0 (2024) |
| Boston Scientific Corporation | $169.02 | 1 | $0 (2018) |
| Tolmar, Inc. | $42.00 | 1 | $0 (2023) |
| Covidien LP | $15.41 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $13.07 | 1 | $0 (2017) |
| KARL STORZ Endoscopy-America | $12.47 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,000 | 2 | INTUITIVE SURGICAL, INC. ($3,000) |
| 2023 | $42.00 | 1 | Tolmar, Inc. ($42.00) |
| 2019 | $27.88 | 2 | Covidien LP ($15.41) |
| 2018 | $169.02 | 1 | Boston Scientific Corporation ($169.02) |
| 2017 | $13.07 | 1 | Janssen Pharmaceuticals, Inc ($13.07) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | INTUITIVE SURGICAL, INC. | DAVINCI XI (Device) | Education | In-kind items and services | $1,500.00 | General |
| Category: SURGERY | ||||||
| 04/18/2024 | INTUITIVE SURGICAL, INC. | DAVINCI XI (Device) | Education | In-kind items and services | $1,500.00 | General |
| Category: SURGERY | ||||||
| 03/02/2023 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Education | In-kind items and services | $42.00 | General |
| Category: Endogenous Testosterone Replacement Therapy | ||||||
| 12/11/2019 | Covidien LP | Parietene (Device) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Hernia Repair | ||||||
| 04/03/2019 | KARL STORZ Endoscopy-America | CMOS VIDEO URETEROSCOPE, 8.5 FR. X 700MM (Device) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: UROLOGY | ||||||
| 04/21/2018 | Boston Scientific Corporation | GENERAL KIDNEY STONE DISEASE (Device) | Food and Beverage | In-kind items and services | $169.02 | General |
| Category: KIDNEY STONE DISEASE | ||||||
| 10/02/2017 | Janssen Pharmaceuticals, Inc | ZYTIGA (Drug) | Education | In-kind items and services | $13.07 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,086 | 4,871 | $1.1M | $230,660 |
| 2022 | 19 | 2,845 | 4,700 | $1.0M | $219,165 |
| 2021 | 19 | 3,019 | 4,909 | $1.1M | $237,493 |
| 2020 | 18 | 2,804 | 4,868 | $989,349 | $203,113 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 559 | 859 | $307,522 | $72,319 | 23.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 177 | 224 | $172,704 | $41,346 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 162 | 162 | $90,072 | $17,620 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 208 | 270 | $64,530 | $16,323 | 25.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 116 | $45,500 | $15,728 | 34.6% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 28 | 30 | $79,500 | $9,517 | 12.0% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 34 | 35 | $32,410 | $9,018 | 27.8% |
| 51705 | Simple change of bladder tube | Office | 2023 | 12 | 96 | $24,288 | $6,904 | 28.4% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 745 | 1,572 | $31,440 | $6,194 | 19.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 445 | 569 | $20,484 | $4,780 | 23.3% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 19 | 98 | $11,172 | $4,543 | 40.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 466 | 597 | $39,999 | $4,366 | 10.9% |
| 52352 | Removal or manipulation of stone in ureter or kidney using an endoscope | Facility | 2023 | 15 | 16 | $32,000 | $4,185 | 13.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 30 | 30 | $15,000 | $3,339 | 22.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $10,925 | $3,174 | 29.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 30 | 30 | $25,470 | $2,915 | 11.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $13,604 | $2,627 | 19.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 26 | 29 | $21,450 | $2,056 | 9.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 15 | $4,525 | $1,420 | 31.4% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 30 | 30 | $19,920 | $1,411 | 7.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 32 | $4,160 | $874.88 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 535 | 890 | $318,620 | $76,101 | 23.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 174 | 226 | $174,246 | $43,140 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 213 | 293 | $70,027 | $15,797 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 122 | 122 | $67,832 | $13,136 | 19.4% |
About Dr. Stephen Holst, MD
Dr. Stephen Holst, MD is a Urology healthcare provider based in Sheridan, Wyoming. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295896751.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Holst, MD has received a total of $3,252 in payments from pharmaceutical and medical device companies, with $3,000 received in 2024. These payments were reported across 7 transactions from 6 companies. The most common payment nature is "Education" ($3,055).
As a Medicare-enrolled provider, Holst has provided services to 11,754 Medicare beneficiaries, totaling 19,348 services with total Medicare billing of $890,431. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Sheridan, WY
- Active Since 12/12/2006
- Last Updated 10/30/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1295896751
Products in Payments
- DAVINCI XI (Device) $3,000
- GENERAL KIDNEY STONE DISEASE (Device) $169.02
- JATENZO (Drug) $42.00
- Parietene (Device) $15.41
- ZYTIGA (Drug) $13.07
- CMOS VIDEO URETEROSCOPE, 8.5 FR. X 700MM (Device) $12.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.